UK 1st National Health Service (NHS) EndoBarrier Service: Outcomes in 1st 38 Patients to Reach 6 Months after Device Explant
Our data demonstrate EndoBarrier as highly effective in patients with refractory diabesity. Maintenance of improvement after EndoBarrier removal was achieved in 68%. There were high patient satisfaction levels and an acceptable safety profile. As endoscopy units are...First Risk-Benefit Data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry
The effects of EndoBarrier therapy on glycaemic control, weight and blood pressure are likely to reduce the complications of type 2 diabetes. This 1st international data from the EndoBarrier worldwide registry suggests that the likely benefits of EndoBarrier...Cost-Effectiveness Analysis of the EndoBarrier Device in Patients with Type 2 Diabetes
There are multiple pharmacotherapy options for type 2 diabetes mellitus (T2DM) including injectable glucagon-like peptide 1 receptor agonists (GLP-1RA). EndoBarrier is an innovative impermeable liner implanted endoscopically into the proximal intestine for up to one...EndoBarrier as a Pre Bariatric Surgical Intervention in High-Risk Patients: a Feasibility Study
Endoscopically placed duodenal-jejunal bypass sleeve (EndoBarrier) has been designed to achieve weight loss and improve glycaemic control in morbidly obese patients with clinically proven effectiveness. The aim of this study was to assess if pre-operative insertion of...Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes
A total of 1,064 studies were identified, 147 of which were duplicates. After abstract review, 741 studies were excluded, leaving 176 articles for full manuscript review. Full article review resulted in 17 studies that satisfied all criteria and therefore were...Medscape
Efforts are being made to kick-start further development of a duodenal-jejunal bypass liner, the EndoBarrier (GI Dynamics), this time specifically for use in obese patients with type 2 diabetes, after some issues with the device in earlier trials.Efforts to Resurrect EndoBarrier for Use in Obese With Diabetes
Medscape article by author Marlene Busko.A Randomised Controlled Trial of a Duodenal-Jejunal Bypass Sleeve Device (EndoBarrier) Compared with Standard Medical Therapy for the Management of Obese Subjects with Type 2 Diabetes Mellitus
Endoscopically placed duodenal-jejunal bypass sleeve devices, such as the EndoBarrier (GI Dynamics, Lexington, Massachusetts, USA), have been designed to create an impermeable barrier between chyme exiting the stomach and the mucosa of the duodenum and proximal...Healthcare Global
New EndoBarrier tech looks set to rival traditional gastric bypass surgery.Videos
How EndoBarrier Works
EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
Maintenance of Efficacy after EndoBarrier
UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
BBC News Item
EndoBarrier treatment for diabetes & obesity following 1 year results …
